Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovarian cancer.

H R Barber

    CA: a Cancer Journal for Clinicians
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Early diagnosis significantly improves ovarian cancer survival rates. Prompt identification and comprehensive treatment, including surgery and chemotherapy, offer optimism for patients and better long-term outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Malignant disease in pregnancy.

    Journal of perinatal medicine·2001
    Same author

    The making of a gynecologic oncologist.

    European journal of gynaecological oncology·2001
    Same author

    Microsatellite instability in human solid tumors.

    Cancer·1998
    Same author

    Total pelvic exenteration.

    Cancer·1998
    Same author

    bcl-2 and p53 in endometrial adenocarcinoma.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·1997
    Same author

    Preoperative and postoperative care of the elderly woman.

    Clinical obstetrics and gynecology·1996
    Same journal

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same journal

    Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

    CA: a cancer journal for clinicians·2026
    Same journal

    Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

    CA: a cancer journal for clinicians·2026
    Same journal

    Correction to "Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases".

    CA: a cancer journal for clinicians·2026
    See all related articles

    Area of Science:

    • Gynecology
    • Oncology

    Background:

    • Ovarian cancer has a high mortality rate, necessitating early detection for improved outcomes.
    • Persistent gastrointestinal symptoms in women over 40 warrant investigation for ovarian cancer.
    • Most ovarian tumors (90%) are of epithelial origin.

    Purpose of the Study:

    • To emphasize the critical role of early diagnosis in reducing ovarian cancer mortality.
    • To outline current treatment strategies and their impact on patient survival.
    • To highlight the connection between ovarian cancer and gastrointestinal issues.

    Main Methods:

    • Surgical interventions including total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and appendectomy.
    • Chemotherapy for advanced stages (IIb, III, IV) and individualized consideration for earlier stages (I, IIa).

    Related Experiment Videos

  • Optional use of P32 instillation.

    • Main Results:

    • Earlier diagnosis, driven by public and professional education, increases the chance of cure.
    • Integrated treatment approaches are leading to longer and more comfortable lives for ovarian cancer patients.
    • Indications suggest an increase in long-term survival rates.

    Conclusions:

    • Early diagnosis remains the most effective strategy against ovarian cancer.
    • Optimal surgical management and referral to specialized centers are crucial for patient care.
    • Current treatments offer a more optimistic outlook for ovarian cancer patients compared to previous decades.